Related Experiment Video
Updated: May 11, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Scientific competency questions as the basis for semantically enriched open pharmacological space development
Kamal Azzaoui1, Edgar Jacoby, Stefan Senger
1Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.
Drug Discovery Today
|May 25, 2013
Summary
Molecular information systems are crucial for data-driven drug discovery, enabling new insights. This review details requirements for an open pharmacological space (OPS) information system integrating compound-target-pathway-disease data.
Area of Science:
- Pharmacology and Cheminformatics
- Drug Discovery Informatics
- Computational Biology
Background:
- Molecular information systems are vital for modern data-driven drug discovery.
- These systems support decision-making and enable new discoveries through association and inference.
- The Innovative Medicines Initiative (IMI) Open PHACTS consortium identified key scientific requirements.
Purpose of the Study:
- To outline scientific requirements for an open pharmacological space (OPS) information system.
- To focus on integrating compound-target-pathway-disease/phenotype data for drug discovery research.
- To analyze scientific competency questions and their underlying data concepts.
Main Methods:
- Reviewing scientific requirements from the IMI Open PHACTS consortium.
- Analyzing competency questions to understand data concepts and associations.
- Presenting publicly available data sources and semantic web technologies.
Main Results:
- Identified scientific requirements for an OPS information system.
- Demonstrated the need for integrating diverse drug discovery data.
- Highlighted the potential of semantic web technologies for data integration.
Conclusions:
- An open pharmacological space (OPS) information system is essential for advancing drug discovery.
- Effective integration of compound, target, pathway, and disease data is critical.
- Semantic web technologies offer promising solutions for building such integrated systems.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...